Drug intelligence / Profile preview

Glucemedin

Development stage
Unknown
Lead developer
NutriMed
Modality
Small Molecules
Administration
Oral
01

Overview

Glucemedin is a multi-ingredient dietary supplement developed by NutriMed Group, primarily indicated for the management of blood glucose levels in individuals with type 2 diabetes mellitus or metabolic syndrome. It is formulated with standardized herbal extracts, including Gymnema sylvestre, Momordica charantia (bitter melon), and Cinnamomum cassia (cinnamon). The mechanism of action involves the synergistic effects of its components: Gymnema sylvestre contains gymnemic acids that may reduce intestinal glucose absorption and enhance insulin secretion; Momordica charantia contains charantin and polypeptide-p, which mimic insulin activity; and Cinnamomum cassia improves insulin sensitivity by enhancing glucose uptake in peripheral tissues.

Brand names
Glucemedin
Other names
Глюцемедин
02

Targets

Sucrase-IsomaltaseINSR (Insulin receptor)SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)

Beyond the preview

Go deeper on Glucemedin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucemedin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call